Oligomerisation of G-protein-coupled receptors.
A range of approaches have recently provided evidence that G-protein-coupled receptors can exist as oligomeric complexes. Both homo-oligomers, comprising multiple copies of the same gene product, and hetero-oligomers containing more than one receptor have been detected. In several, but not all, examples, the extent of oligomerisation is regulated by the presence of agonist ligands, and emerging evidence indicates that receptor hetero-oligomers can display distinct pharmacological characteristics. A chaperonin-like role for receptor oligomerisation in effective delivery of newly synthesised receptors to the cell surface is a developing concept, and recent studies have employed a series of energy-transfer techniques to explore the presence and regulation of receptor oligomerisation in living cells. However, the majority of studies have relied largely on co-immunoprecipitation techniques, and there is still little direct information on the fraction of receptors existing as oligomers in intact cells.
Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK. g.milligan@bio.gla.ac.uk
G
G
Milligan
D000818:Animals; D018833:Chaperonins / Q000378:metabolism / Q000502:physiology; D019281:Dimerization; D019204:GTP-Binding Proteins / Q000378:metabolism*; D006801:Humans; D008024:Ligands; D009842:Oligopeptides / Q000378:metabolism / Q000502:physiology; D011233:Precipitin Tests; D011956:Receptors, Cell Surface / Q000378:metabolism* / Q000502:physiology; D018079:Receptors, GABA / Q000378:metabolism
D008024:Ligands; D009842:Oligopeptides; D011956:Receptors, Cell Surface; D018079:Receptors, GABA; D018833:Chaperonins; D019204:GTP-Binding Proteins